LouisBNaborsIIIMD

Clinical Trials

• EMD 121974 in Treating Patients With Progressive or Recurrent Glioma Start of enrollment: 2000 Sep 01

  Completed

  Phase 1, Phase 2

• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2005 Apr 01

  Completed

  Phase 1, Phase 2

• Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Dec 01

  Completed

  Phase 1

• A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2003 Aug 01

  Completed

  Phase 1

• ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2009 Jul 13

  Completed

  Phase 1

• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status Start of enrollment: 2009 Mar 01

  Completed

  Phase 2

• Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2010 Jul 01

  Completed

  Phase 2

• A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma Start of enrollment: 2012 Jan 01

  Completed

  Not Applicable

• A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Start of enrollment: 2013 May 06

  Completed

  Phase 2

• A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients Start of enrollment: 2011 Apr 01

  Completed

  Early Phase 1

• Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma Start of enrollment: 2013 Aug 01

  Suspended

  Phase 1, Phase 2

• Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy Start of enrollment: 2014 Jan 01

  Terminated

  Phase 2

• Join now to see all